Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sarah Kopecky-Bromberg"'
Autor:
Graham R Foster, Tarik Asselah, Sarah Kopecky-Bromberg, Yang Lei, Armen Asatryan, Roger Trinh, Neddie Zadeikis, Federico J Mensa
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0208506 (2019)
Finding safe and effective treatments for chronic hepatitis C virus (HCV) infection in the elderly is of clinical interest given the comorbidities and associated polypharmacy in this population. However, the number of patients older than age 65 years
Externí odkaz:
https://doaj.org/article/9c864066df244f1ba8d3c5efb5ac4efc
Autor:
David L. Wyles, Yves Horsmans, Erica Villa, Sarah Kopecky-Bromberg, Tania M. Welzel, Armen Asatryan, Preethi Krishnan, Federico J. Mensa, Stephen D. Ryder, Roger Trinh, Ola Weiland, David Mutimer, Peter Ruane, Stanley Wang, Edward Gane, Teresa I. Ng, Jürgen K. Rockstroh, Sandra S. Lovell, Zhenyi Xue, Jeong Heo, Kosh Agarwal, Paul Y. Kwo, Steven L. Flamm
Publikováno v:
Journal of Viral Hepatitis
Journal of viral hepatitis, Vol. 26, no. 3, p. 337-349 (2019)
Journal of viral hepatitis, Vol. 26, no. 3, p. 337-349 (2019)
Summary Glecaprevir coformulated with pibrentasvir (G/P) is approved to treat hepatitis C virus (HCV) infection and was highly efficacious in phase 2 and 3 studies. Treating HCV genotype (GT) 3 infection remains a priority, as these patients are hard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5cd9e034b34fe732ed08057948ded30
https://doi.org/10.1111/jvh.13038
https://doi.org/10.1111/jvh.13038
Autor:
Gamal Esmat, Reham Soliman, Naglaa Allam, N. Mobashery, Mohamed Hassany, Gamal Shiha, Sarah Kopecky-Bromberg, Negar N. Alami, Mohammad A. Mohey, Coleen Hall, Rabab Fouad, Roula B. Qaqish, Imam Waked
Publikováno v:
Journal of Medical Virology
In AGATE‐II, treatment with ombitasvir coformulated with paritaprevir/ritonavir plus ribavirin (RBV) in Egyptians infected with hepatitis C virus genotype 4 resulted in high rates of sustained virologic response at post‐treatment week 12. This su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5947b56beb9f4c3738d73cebfdd0ebd
https://doi.org/10.1002/jmv.25243
https://doi.org/10.1002/jmv.25243
Autor:
David R. Shaw, Yang Lei, Joel Gallant, Robert Reindollar, Sarah Kopecky-Bromberg, Stephen Pianko, Maria Buti, Stanislas Pol, Jens Kort, Armen Asatryan, Michael W. Fried, Preethi Krishnan, C.-W. Lin, Stuart C. Gordon, Fred Poordad, Christophe Hézode, Federico J. Mensa, Franco Felizarta, Teresa I. Ng, David E. Bernstein
Publikováno v:
Hepatology (Baltimore, Md.)
Methods: MAGELLAN-1 Part 2 was a randomized, open-label, phase 3 study to evaluate the efficacy and safety of ribavirin (RBV)-free glecaprevir and pibrentasvir (G/P; 300 mg/120 mg) in patients with chronic HCV and prior virologic failure on at least
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134f71533e69d468f368f6e948adc780
https://doi.org/10.1002/hep.29671
https://doi.org/10.1002/hep.29671
Autor:
Tarik Asselah, Yang Lei, Sarah Kopecky-Bromberg, Federico J. Mensa, Roger Trinh, Neddie Zadeikis, Armen Asatryan, Graham R. Foster
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 1, p e0208506 (2019)
PLoS ONE, Vol 14, Iss 1, p e0208506 (2019)
Finding safe and effective treatments for chronic hepatitis C virus (HCV) infection in the elderly is of clinical interest given the comorbidities and associated polypharmacy in this population. However, the number of patients older than age 65 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68fab6405ff47de1ecffa79f83a89d47
https://doi.org/10.1371/journal.pone.0208506
https://doi.org/10.1371/journal.pone.0208506
Publikováno v:
Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Dec2019, Vol. 35 Issue 12, p2670-2686. 17p.
Autor:
Flamm, Steven1 s-flamm@northwestern.edu, Mutimer, David2, Asatryan, Armen3, Wang, Stanley3, Rockstroh, Jürgen4, Horsmans, Yves5, Kwo, Paul Y.6, Weiland, Ola7, Villa, Erica8, Heo, Jeong9, Gane, Edward10, Ryder, Stephen D.11, Welzel, Tania M.12, Ruane, Peter J.13, Agarwal, Kosh14, Ng, Teresa I.3, Xue, Zhenyi3, Lovell, Sandra S.3, Krishnan, Preethi3, Kopecky‐Bromberg, Sarah3
Publikováno v:
Journal of Viral Hepatitis. Mar2019, Vol. 26 Issue 3, p337-349. 13p.
Autor:
Foster, Graham R.1 g.r.foster@qmul.ac.uk, Asselah, Tarik2, Kopecky-Bromberg, Sarah3, Lei, Yang3, Asatryan, Armen3, Trinh, Roger3, Zadeikis, Neddie3, Mensa, Federico J.3
Publikováno v:
PLoS ONE. 1/2/2019, Vol. 14 Issue 01, p1-13. 13p.
Autor:
Waked, Imam, Esmat, Gamal, Fouad, Rabab, Allam, Naglaa, Hassany, Mohamed, Mohey, Mohammad, Shiha, Gamal, Soliman, Reham, Qaqish, Roula B., Hall, Coleen, Alami, Negar N., Kopecky‐Bromberg, Sarah, Mobashery, Niloufar
Publikováno v:
Journal of Medical Virology; Nov2018, Vol. 90 Issue 11, p1739-1744, 6p
Autor:
Da Silva, Barbara, Tschampa, Jean, Beron, Jörg, Fredrick, Linda, Patwardhan, Meenal, Zachry, Woodie, Woodward, William C., Norton, Michael, Nilius, Angela
Publikováno v:
International Journal of Clinical Pharmacology & Therapeutics; 2012, Vol. 50 Issue 6, p391-402, 12p